Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status: Enrolling

Conditions: Musculoskeletal System Disease

Treatments: Combination Product: PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices

Study type: Observational

Funder types: Other

Identifiers

NCT04711551

REGAIN

Details and patient eligibility

About

the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study.

patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments.

Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients who received indication for regerative medicine treatment for one of the following pathologies: Knee or hip or ankle osteoarthritis, patellar or Achilles tendon pain, shouder or elbow pain;
• males and females;
• age >= 6 years.

Exclusion criteria

• age < 6 years
• patients not compliant with post-treatment monitoring procedures
• pregnancy